Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 crore

Suven will purchase100% of share capital from CPPL existing investors. Suven didn’t provide details like annual turnover of the acquired asset citing that CPPL is yet to reach commercially viable operations.